Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
Amélie Bos(Amsterdam Institute for Addiction Research), Marjolein van Egmond(Amsterdam Institute for Addiction Research)
Cited by 6
Related Papers
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
|Journal of Clinical Investigation|2021|59
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
|Cancers|2022|35
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
|Frontiers in Immunology|2023|12